Skip to main content
Tech.euFundingExplorerBeta

Comphya

Comphya developing an active implantable medical device to restore the erectile function of patient non-responsive to oral drugs.

Comphya has raised €9.9M across 3 funding rounds from 2 investors, most recently a Series A round in Jul 2025. Based in Zurich, Switzerland; founded 2017; active in Healthtech. Data as of 28 Oct 2026.

Zurich, SwitzerlandFounded 2017www.comphya.com ↗
Total raised
€9.9M
€9,933,519
Funding rounds
3
Investors
2
distinct backers
Active since
2020-12
latest 2025-07

Funding by year

EUR raised per year
Comphya — funding by year — interactive chart.
Data table
Comphya — funding by year
2020€1.1M
2023€847k
2025€8.0M

Signals

Medium confidence
Raise-next likelihood75
base rate 44% for Series A
  • ▲ In typical raise window
  • ▲ Up-round momentum
Exit likelihood9
base rate 11% (2+ rounds)
  • ▲ 9y since founding (typical exit age)
  • ▼ No recent equity round (debt-only or quiet)

Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

3 rounds
DateStageAmountInvestors
2025-07-08Series A€8.0M—View deal →
2023-01-31Debt€847kExisting investors,Praxis Spinal Cord InstituteView deal →
2020-12-02Seed€1.1M—View deal →

Investors

2

Similar companies

same sector or country

Global coverage: FundingData